At any given time, Siteman Cancer Center investigators conduct more than 350 active clinical trials, each carefully monitored and regulated to safeguard patient safety and privacy. This includes a variety of trials for all types of hematologic and non-hematologic malignancies in multiple modalities evaluating current standard of care therapies as well as experimental treatments. In addition to phase I trials offered through our Phase I Program, there are a large number of trials evaluating chemotherapies, radiation therapies, immunotherapies, surgical approaches, and behavioral interventions, as well as non-therapeutic studies looking at quality of life, results of novel imaging techniques, and outcomes of specimen analyses.
Health-care providers interested in learning whether Siteman offers trials that may benefit their patients can click here to search our online directory of open trials. Providers may search for trials by disease type, keyword, principal investigator, location and protocol number.
For general inquiries regarding clinical trial availability or specific information about individual trials listed on this site, call our referral specialists at 314-747-3046 or toll-free 877-251-6485 from 8 a.m. to 4:30 p.m. Central Standard Time Monday through Friday. You also can contact us via e-mail.